Related Experiment Videos

A mutant alpha subunit of Gi2 induces neoplastic transformation of Rat-1 cells

A M Pace1, Y H Wong, H R Bourne

  • 1Department of Pharmacology, University of California, San Francisco 94143.

Insights

The gip2 oncogene, a mutant alpha subunit of Gi2 (guanine nucleotide-binding protein), drives cancer development in Rat-1 cells. This tissue-selective oncogene promotes neoplastic transformation and tumor formation in specific cell types.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Oncogenes can arise from GTPase-inhibiting mutations that constitutively activate alpha subunits of G proteins.
  • Somatic mutations in endocrine tumors at the arginine-179 codon of the alpha subunit of Gi2 (alpha i2) create the gip2 oncogene.

Purpose of the Study:

  • To investigate the oncogenic potential of gip2.
  • To determine if gip2 can induce neoplastic transformation in fibroblasts.

Main Methods:

  • Expression of a mutant alpha i2 cDNA (alpha i2-R179C) in Rat-1 and NIH 3T3 fibroblasts.
  • Assessment of cellular growth, anchorage dependence, and tumor formation in nude mice.

Main Results:

  • Expression of alpha i2-R179C induced higher cell density, loss of anchorage dependence, and subcutaneous tumor formation in Rat-1 cells.
  • Alpha i2-R179C expression did not alter the growth or tumorigenicity of NIH 3T3 cells.

Conclusions:

  • Gip2 functions as an oncogene by inducing neoplastic transformation in Rat-1 cells.
  • The tissue-selective activity of gip2 is supported by its failure to transform NIH 3T3 cells, aligning with clinical observations.

Related Concept Videos